Lantern Pharma Inc.
Lantern Pharma Inc. scores highest on Torque (41) and lowest on Price (0). Its PosiPenta is 23.99 out of 100, weaker than most similar companies.
On the Penta Grid this week, Lantern Pharma Inc. is Grid #816 of 837 in the Healthcare sector in United States, and Grid #3,846 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Lantern Pharma Inc. | 23.99 | 0 | 27 | 16 | 41 | 36 |
| IN8bio, Inc. | 43.40 | 44 | 44 | 39 | 38 | 52 |
| Palatin Technologies, Inc. | 31.57 | 39 | 36 | 20 | 33 | 30 |
| Ensysce Biosciences, Inc. | 29.78 | 0 | 53 | 29 | 27 | 40 |
| MetaVia Inc. | 33.07 | 37 | 19 | 16 | 42 | 51 |
| Bullfrog AI Holdings, Inc. | 40.93 | 35 | 63 | 28 | 48 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.41 |
| P/B ratio | -3.10 |
EEarnings
| Trailing EPS | ₹-154.39 |
| Forward EPS | ₹-191.32 |
NNitro
| Price | 63.31 |
| 52-week high | 411.06 |
| 52-week low | 59.21 |
| Fall from 52-week high | 84.6% |
TTorque
| Return on equity (ROE) | -400.92% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 2.32 |
| Market cap | ₹94 Cr |
| Insider holding | 17.36% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Lantern Pharma Inc.'s PosiPenta score?
Lantern Pharma Inc.'s PosiPenta is 23.99 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Lantern Pharma Inc. stand on the Penta Grid?
On the Penta Grid this week, Lantern Pharma Inc. is Grid #816 of 837 in the Healthcare sector in United States, and Grid #3,846 of 4,000 in United States.
Which PosiPenta pillar is strongest for Lantern Pharma Inc.?
Torque (durability), with a score of 41 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Lantern Pharma Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.